Helen Chifotides

Research output

Research output per year 1992 2003 2005 2006 2007 2008 2013 2020 2022 2023 2024

• 36 Article
• 11 Review article
• 2 Chapter
• 1 Paper

Research output per year

Research output per year

Search results

• 2024

  ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis

  Duminuco, A., Chifotides, H. T., Giallongo, S., Giallongo, C., Tibullo, D. & Palumbo, G. A., Jan 2024, In: Cancers. 16, 1, 154.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Primary Myelofibrosis 100%
  • Anemia 67%
  • N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 66%
  • Hepcidins 60%
  • 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 45%
• 2023

  Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments

  Chifotides, H. T., Verstovsek, S. & Bose, P., Jul 2023, In: Cancers. 15, 13, 3331.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Primary Myelofibrosis 100%
  • Phenotype 47%
  • Splenomegaly 33%
  • Survival 22%
  • 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 19%
  3 Scopus citations

• Biological drivers of clinical phenotype in myelofibrosis

  Mascarenhas, J., Gleitz, H. F. E., Chifotides, H. T., Harrison, C. N., Verstovsek, S., Vannucchi, A. M., Rampal, R. K., Kiladjian, J. J., Vainchenker, W., Hoffman, R., Schneider, R. K. & List, A. F., Feb 2023, In: Leukemia. 37, 2, p. 255-264 10 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Primary Myelofibrosis 100%
  • Phenotype 47%
  • Myeloproliferative Disorders 17%
  • Mutation 14%
  • Thrombocytopenia 12%
  13 Scopus citations

• SOHO State of the Art Updates and Next Questions: Novel Therapeutic Strategies in Development for Myelofibrosis

  Chifotides, H. T., Masarova, L. & Verstovsek, S., Apr 2023, In: Clinical Lymphoma, Myeloma and Leukemia. 23, 4, p. 219-231 13 p.

  Research output: Contribution to journal › Review article › peer-review

  • Primary Myelofibrosis 100%
  • INCB018424 55%
  • N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 34%
  • Survival 19%
  • imetelstat 17%
  2 Scopus citations
• 2022

  Momelotinib: an emerging treatment for myelofibrosis patients with anemia

  Chifotides, H. T., Bose, P. & Verstovsek, S., Dec 2022, In: Journal of Hematology and Oncology. 15, 1, 7.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 100%
  • Primary Myelofibrosis 64%
  • Anemia 43%
  • INCB018424 17%
  • Janus Kinase Inhibitors 16%
  36 Scopus citations

• SOHO State of the Art Updates and Next Questions: Novel Therapies in Development for Myelofibrosis

  Chifotides, H. T., Bose, P., Masarova, L., Pemmaraju, N. & Verstovsek, S., Apr 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, 4, p. 210-223 14 p.

  Research output: Contribution to journal › Review article › peer-review

  • Primary Myelofibrosis 100%
  • INCB018424 99%
  • imetelstat 64%
  • Janus Kinase Inhibitors 44%
  • Anemia 40%
  8 Scopus citations

• Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update

  El Hussein, S., Chifotides, H. T., Khoury, J. D., Verstovsek, S. & Thakral, B., Jul 2022, In: Cancers. 14, 14, 3474.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Systemic Mastocytosis 100%
  • Mast Cells 66%
  • Mast-Cell Leukemia 32%
  • Mastocytosis 27%
  • midostaurin 16%
  8 Scopus citations
• 2021

  Accelerated Phase of Myeloproliferative Neoplasms

  Shahin, O. A., Chifotides, H. T., Bose, P., Masarova, L. & Verstovsek, S., Sep 1 2021, In: Acta haematologica. 144, 5, p. 484-499 16 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Neoplasms 100%
  • Primary Myelofibrosis 97%
  • INCB018424 60%
  • Acute Myeloid Leukemia 36%
  • Mutation 32%
  27 Scopus citations
• 2013

  Anion-π interactions in supramolecular architectures

  Chifotides, H. T. & Dunbar, K. R., Apr 16 2013, In: Accounts of Chemical Research. 46, 4, p. 894-906 13 p.

  Research output: Contribution to journal › Review article › peer-review

  • Anion 100%
  • Tetrazine 39%
  • NMR Data 28%
  • X-Ray 25%
  • 19F Solid-State Nuclear Magnetic Resonance Spectroscopy 24%
  443 Scopus citations
• 2008

  Anion-Π interactions

  Schottel, B. L., Chifotides, H. T. & Dunbar, K. R., Dec 17 2008, In: Chemical Society Reviews. 37, 1, p. 68-83 16 p.

  Research output: Contribution to journal › Review article › peer-review

  • Anion 95%
  • Force 55%
  • Electron Particle 44%
  981 Scopus citations
• 2005

  Interactions of metal - Metal-bonded antitumor active complexes with DNA fragments and DNA

  Chifotides, H. T. & Dunbar, K. R., Feb 2005, In: Accounts of Chemical Research. 38, 2, p. 146-156 11 p.

  Research output: Contribution to journal › Review article › peer-review

  • Purine Nucleobase 100%
  • Double-Stranded DNA 65%
  • Electron Acceptor 57%
  • Antitumor 56%
  • NMR Spectroscopy 41%
  422 Scopus citations